Home/Filings/4/0001437749-23-006105
4//SEC Filing

Kjems Lise Lund 4

Accession 0001437749-23-006105

CIK 0000922247other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 11:38 AM ET

Size

5.0 KB

Accession

0001437749-23-006105

Insider Transaction Report

Form 4
Period: 2023-03-07
Kjems Lise Lund
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to buy)

    2023-03-07+55,45355,453 total
    Exercise: $1.28Exp: 2033-03-07Common Stock (55,453 underlying)
Footnotes (1)
  • [F1]The option vests over a four year period in equal monthly installments.

Issuer

Cyclo Therapeutics, Inc.

CIK 0000922247

Entity typeother

Related Parties

1
  • filerCIK 0001884844

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 11:38 AM ET
Size
5.0 KB